
Upexi held 2.36M SOL worth $184.9M, generating $3.5M in staking revenue. A $92.3M mark-to-market loss on its Solana position drove a $109.3M net loss.
Alpha Score of 35 reflects weak overall profile with weak momentum, weak value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Upexi reported a net loss of $109.3 million for its fiscal third quarter, a result almost entirely shaped by a $92.3 million unrealized loss on its digital asset holdings. The company disclosed it held 2.36 million SOL tokens at the end of March, with a fair value of $184.9 million. The mark-to-market hit on that Solana position turned what would have been a modest operating result into a nine-figure loss. Upexi’s core e-commerce and brand management operations generated revenue that was completely overshadowed by the crypto loss. The loss underscores the balance-sheet risk that comes with holding a concentrated crypto position, a theme we track in our crypto market analysis.
The $92.3 million unrealized loss flows directly from the gap between Upexi’s cost basis and the quarter-end price of SOL. With 2.36 million tokens valued at $184.9 million on March 31, the implied price per SOL was roughly $78. Adding back the unrealized loss suggests an average cost basis near $117 per token. That $39 per-token decline over the holding period produced the non-cash charge that dominated the income statement.
This is a pure mark-to-market adjustment under accounting rules that require digital assets to be carried at fair value. The loss does not reflect any sale of tokens. It does, however, make Upexi’s reported earnings highly sensitive to SOL’s price swings. A recovery in SOL after quarter-end would reverse some or all of the unrealized loss in future periods. Further declines would deepen the red ink.
Beyond the price-driven volatility, Upexi’s Solana holdings generated $3.5 million in staking revenue during the quarter. Staking involves locking tokens to help secure the network in exchange for rewards. The revenue provides a recurring yield on the position, offering a small offset to operating costs. The yield is modest relative to the $184.9 million position. It represents a cash inflow that does not depend on token sales, and it demonstrates that the SOL position can generate income even during price declines.
The size of the position–2.36 million SOL–makes Upexi one of the larger corporate holders of Solana. Any decision to reduce or add to the stake would move the market’s perception of the stock. For now, the company has not indicated plans to sell, leaving the position as a long-duration bet on the Solana ecosystem. The quarter coincided with a broader pullback in crypto markets. SOL and other major tokens declined, compressing the fair value of the holdings.
The earnings report resets the investment case for Upexi. The operating business is now a footnote to the crypto balance sheet. A $92.3 million unrealized loss on a $184.9 million position means a 50% drawdown from cost wipes out reported profits. The stock will trade less on quarterly revenue and more on the spot price of SOL. The market may assign a discount to the net asset value due to the illiquidity of a large token position and the risk of a forced sale.
This dynamic creates a clear decision point. The next quarterly filing will capture SOL’s price as of June 30. If SOL has rallied from the $78 level, Upexi could report a large unrealized gain that flips the bottom line. If SOL has weakened, the loss could expand. Traders treating Upexi as a Solana proxy should track the token’s price daily and watch for any filing that discloses a change in the number of tokens held. The $3.5 million in staking revenue adds a small recurring yield. The primary driver of the stock’s direction will be the mark-to-market adjustment on 2.36 million SOL.
Drafted by the AlphaScala research model and grounded in primary market data – live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.